Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the cross-presentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“hypoxic tumors have been shown to exhibit decreased MHC-I expression in tumor cells and DCs (Ramakrishnan et al., 2014).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Ramakrishnan et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 1×
“generation of cells with immune-suppressive activity, including regulatory DCs and myeloid-derived suppressor cells (4).”
BackgroundSelf-citationBatf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081
Lipid Droplets and Cellular Lipid Metabolism
Walther, T. C., & Farese, R. V. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061009-102430 · Cited by 1,661 · cited 1×
“The presence and size of LBs is defined by the accumulation of FA precursors and their esterification into TAGs and CEs, the major constituents of the hydrophobic core of LBs (26).”
BackgroundCross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637 · cited 2×
“The endogenous pathway of presentation invariably depends on proteasomes, whereas the pathway of cross-presentation (cytosolic or vacuolar) depends on the type of Ag and the mechanism of its uptake (12, 35).”
BackgroundMechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
Self-citationBevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956 · cited 1×
“generate peptide T cell epitopes that are presented by MHC class I (MHC-I) molecules (9, 10).”
BackgroundLipid accumulation and dendritic cell dysfunction in cancer
Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lennox, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 735
Self-citationEndoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages
Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J. M., & Desjardins, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00797-3 · Cited by 683 · cited 1×
“In addition to recycling MHC-I, transport of MHC-I, from ER to the endocytic compartment, has also been demonstrated (49, 50).”
BackgroundMechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
Cited by
Items 101–200 of 328
Chen, J., Levy, A., Tian, A.-L., Huang, X., Cai, G., Fidelle, M., Rauber, C., Ly, P., Pizzato, E., Sitterle, L., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.010 · Cited by 67
Zhao, N., Li, Y., Yang, W., Zhuang, J., Li, Y., & Li, N. (2019) · Chemical Science · doi:10.1039/c9sc03111a · Cited by 67
Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 67
Liu, Y., Duan, C., Dai, R., & Zeng, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.739392 · Cited by 65
“Accumulation of lipid within lipid droplets in tumor-associated DCs reduces the antigen presentation, leading to dysfunction of DCs and poor stimulation of T cell responses, thereby modulating anti-tumor immunity (Herber et al., 2010; Ramakrishnan et al., 2014).”
BackgroundInteractions among myeloid regulatory cells in cancer
Umansky, V., Adema, G. J., Baran, J., Brandau, S., Ginderachter, J. A. V., Hu, X., Jabłońska, J., Mojsilović, S. B., Papadaki, H. Α., de Coaña, Y. P., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2200-6 · Cited by 64
Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity
Suryawanshi, A. S., Hussein, M. S., Prasad, P. D., & Manicassamy, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00122 · Cited by 64
“Immature or tolerogenic DCs show a catabolic metabolism that is manifested by increased oxidative phosphorylation, fatty acid oxidation (FAO), and glutaminolysis (61, 63, 64).”
Background“Redox lipidomics technology: Looking for a needle in a haystack”
Tyurina, Y. Y., Tyurin, V. A., Anthonymuthu, T., Amoscato, A. A., Sparvero, L. J., Nesterova, A. M., Baynard, M. L., Sun, W., He, R., Khaitovich, P., et al. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.03.012 · Cited by 58
Self-citationShaping of Innate Immune Response by Fatty Acid Metabolite Palmitate
Tzeng, H., Chyuan, I., & Chen, W. (2019) · Cells · doi:10.3390/cells8121633 · Cited by 63
“and dampens anti-tumor immune response [87].”
Cholesterol: An important actor on the cancer immune scene
Halimi, H., & Farjadian, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057546 · Cited by 62
“It is also showed that oxidized lipids reduce the expression of MHC class I on DCs (65).”
BackgroundInfluentialApaya, M. K., Chang, M., & Shyur, L. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.001 · Cited by 62
ILT4 functions as a potential checkpoint molecule for tumor immunotherapy
Gao, A., Sun, Y., & Peng, G. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.001 · Cited by 61
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 60
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Gong, L., Luo, J., Yang, E., Ru, B., Qi, Z., Yang, Y., Rani, A., Purohit, A., Zhang, Y., Guan, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.004 · Cited by 59
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 59
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
Sica, A., Guarneri, V., & Gennari, A. (2019) · Cell Stress · doi:10.15698/cst2019.09.197 · Cited by 58
“Recent studies have also highlighted the role of energy metabolic pathways in the differentiation and function of myeloid cells [42].”
BackgroundCross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
Audsley, K. M., McDonnell, A. M., & Waithman, J. C. (2020) · Cells · doi:10.3390/cells9030565 · Cited by 58
Strategies to overcome DC dysregulation in the tumor microenvironment
Mestrallet, G., Sone, K., & Bhardwaj, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980709 · Cited by 57
“Lipid-accumulating DCs have reduced T cell activation and cross-presentation (55).”
BackgroundEmerging Roles of Cellular Metabolism in Regulating Dendritic Cell Subsets and Function
Du, X., Chapman, N. M., & Chi, H. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00152 · Cited by 57
Lipid peroxidation of immune cells in cancer
Xiao, L., Xian, M., Zhang, C., Guo, Q., & Yi, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1322746 · Cited by 57
“In addition, it was reported that the main composition of lipids accumulated in tumor supernatant-treated DCs was poly-unsaturated fatty acids (90).”
BackgroundInfluentialZhang, H., Zhao, W., Li, X., & He, Y. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s315998 · Cited by 55
“MHC-type complexes on the cell surface, and thus blocking antigen cross-presentation.(87) The inconsistent role of”
BackgroundProstate Cancer Progression: as a Matter of Fats
Scaglia, N., Frontini-López, Y. R., & Zadra, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719865 · Cited by 55
PPARα at the crossroad of metabolic–immune regulation in cancer
Zeng, W., Yin, X., Jiang, Y., Jin, L., & Liang, W. P. (2021) · FEBS Journal · doi:10.1111/febs.16181 · Cited by 54
Dendritic cell subsets and implications for cancer immunotherapy
Chen, M. Y., Zhang, F., Goedegebuure, S. P., & Gillanders, W. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1393451 · Cited by 53
Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells
Wu, H., Weidinger, C., Schmidt, F., Keye, J., Friedrich, M., Yerinde, C., Willimsky, G., Qin, Z., Siegmund, B., & Glauben, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-07685-9 · Cited by 53
Immune Dysregulation in Obesity
Jiang, Z., Tabuchi, C., Gayer, S. G., & Bapat, S. P. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-015350 · Cited by 52
Wang, J.-Z., Zhang, Y., Guo, X., Zhang, H., & Zhang, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.018 · Cited by 52
Guo, D., Cai, S., Deng, L., Xu, W., Fu, S., Lin, Y., Jiang, T., Li, X., Shen, Z., Zhang, J., et al. (2025) · MedComm · doi:10.1002/mco2.70116 · Cited by 52
Cancer, obesity and immunometabolism – Connecting the dots
Dyck, L., & Lynch, L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.019 · Cited by 51
Perez, V. M., Gabell, J., Behrens, M. R., Wase, N. V., Dirusso, C., & Black, P. N. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012730 · Cited by 51
Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
Salah, A., Wang, H., Li, Y., Ji, M., Ou, W., Qi, N., & Wu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.686544 · Cited by 50
Myeloid Cell–Derived Oxidized Lipids and Regulation of the Tumor Microenvironment
Hicks, K. C., Tyurina, Y. Y., Kagan, V. E., & Gabrilovich, D. I. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3054 · Cited by 49
Self-citationImmunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 50
“The accumulation of lipid droplets in tumor-derived dendritic cells (DCs) with tolerogenic functions leads to impaired antigen presentation and reduced anti-tumor activity 130,131 .”
Chen, I., Awasthi, D., Hsu, C., Song, M., Chae, C.-S., Dannenberg, A. J., & Cubillos‐Ruiz, J. R. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100567 · Cited by 49
Metabolic rewiring and communication in cancer immunity
Chapman, N. M., & Chi, H. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.02.001 · Cited by 49
“115,116 Further, cholesterol uptake by DCs promotes tolerogenic programming that impedes their T cell priming capacity.”
BackgroundProteostasis in the Endoplasmic Reticulum: Road to Cure
Nam, S. M., & Jeon, Y. J. (2019) · Cancers · doi:10.3390/cancers11111793 · Cited by 50
Yang, J., Zhang, M., Zhang, X., Zhou, Y., Ma, T., Liang, J., & Zhang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1439191 · Cited by 46
Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy
Ma, C., Hu, H., Liu, H., Zhong, C., Wu, B., Lv, C., & Tian, Y. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10025-7 · Cited by 47
Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
Gong, Y., Yang, J., Wang, Y., Xue, L., & Wang, J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32990 · Cited by 46
Trempolec, N., Degavre, C., Doix, B., Brusa, D., Corbet, C., & Féron, O. (2020) · Cancers · doi:10.3390/cancers12051284 · Cited by 47
“In parallel, the group of Gabrilovic provided evidence that oxidatively truncated lipids accumulated into LDs could covalently bind to chaperone hsp 70 and thereby impede peptide–MHC class I (pMHC) complex translocation from the phagosome/lysosome compartments to cell surface [33,43].”
BackgroundShaping of Dendritic Cell Function by the Metabolic Micro-Environment
Brombacher, E. C., & Everts, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00555 · Cited by 46
“These oxidized FAs cause accumulation of peptide-bound MHC-I complexes in late endosomes and lysosomes via capturing of heat shock protein 70, an important mediator of cross-presentation (75, 76).”
BackgroundThe role of dendritic cells in cancer immunity and therapeutic strategies
Tai, Y., Chen, M., Wang, F., Fan, Y., Zhang, J., Cai, B., Lin, Y., Luo, Y., & Li, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111548 · Cited by 45
Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications
Lu, J., Chen, S., Bai, X., Liao, M., Qiu, Y., Zheng, L., & Yu, H. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115907 · Cited by 44
Lipid Metabolism Interplay in CRC—An Update
Krauß, D., Fari, O., & Sibilia, M. C. (2022) · Metabolites · doi:10.3390/metabo12030213 · Cited by 43
Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology
Sica, A., & Strauss, L. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr1116-476r · Cited by 42
“the differentiation and function of myeloid cells [42, 43].”
BackgroundZhang, M., Wei, T., Zhang, X., & Guo, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937406 · Cited by 42
“Contrary to this phenomenon, the accumulation of non-oxidized lipids did not affect the cross-presentation ability of DCs (75).”
BackgroundQin, Y., Liu, X., An, J., Liang, J., Li, C., Jin, X., Ji, P., & Zhang, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c06784 · Cited by 41
Li, X., Li, Y., Yu, Q., Qian, P., Huang, H., & Lin, Y. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr0421-597rr · Cited by 41
Tyurina, Y. Y., Shrivastava, I. H., Tyurin, V. A., Mao, G., Dar, H. H., Watkins, S. C., Epperly, M. W., Bahar, İ., Shvedova, A. A., Pitt, B. R., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7124 · Cited by 40
Self-citationNatural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Wang, M., Zhou, Z., Wang, X., Zhang, C., & Jiang, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05041-y · Cited by 41
“High lipid contents in DC block the expression of MHC class I-peptide complex and inhibit tumor antigen cross-presentation [32].”
BackgroundLee, W., Kingstad-Bakke, B. A., Paulson, B. R., Larsen, A., Overmyer, K. A., Marinaik, C. B., Dulli, K., Toy, R., Vogel, G., Mueller, K. P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009168 · Cited by 39
Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity
Yoo, Y.-S., Han, H. G., & Jeon, Y. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2969271 · Cited by 39
Lipid-mediated regulation of the cancer-immune crosstalk
Ma, Y., Zhang, S., Jin, Z., & Shi, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105131 · Cited by 38
Impact of Lipid Metabolism on Antitumor Immune Response
Mabrouk, N., Lecoeur, B., Bettaïeb, A., Paul, C., & Végran, F. (2022) · Cancers · doi:10.3390/cancers14071850 · Cited by 37
“Oxidized lipid accumulation in tumorinfiltrating DCs is associated with antigen cross-presentation function blockade and MHC class II orientation, since DC activity was restored in response to acetyl-CoA carboxylase inhibition [35,36].”
BackgroundA guide to ferroptosis in cancer
Yapici, F. I., Bebber, C. M., & von Karstedt, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13649 · Cited by 36
“Of note, DCs impaired in cross presentation were shown to accumulate oxida-tively truncated lipids from within lipid bodies, leading to intracellular trapping of MHC complexes [165,166].”
BackgroundCell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches
Wang, W., Li, T., & Wu, K. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02376-1 · Cited by 36
TSC1/mTOR-controlled metabolic–epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis
Shi, L., Chen, X., Zang, A., Li, T., Hu, Y., Ma, S., Lü, M., Yin, H., Wang, H., Zhang, X., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000420 · Cited by 35
Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy
Lu, Y., Shi, Y., & You, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.011 · Cited by 35
Mohammadyani, D., Tyurin, V. A., O'Brien, M. B., Sadovsky, Y., Gabrilovich, D. I., Klein‐Seetharaman, J., & Kagan, V. E. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.042 · Cited by 34
“…accumulate LDs: (i) DCs from tumor-bearing animals with elevated levels of CD204 receptor, known to avidly uptake and accumulate lipids from plasma [15,16], and (ii) hypoxic trophoblasts, in which impaired FA oxidation and trafficking are mostly responsible for the dyslipidemia [18].”
BackgroundMethodInfluentialSelf-citationSi, F., Liu, X., Tao, Y., Zhang, Y., Ma, F., Hsueh, E. C., Puram, S. V., & Peng, G. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008219 · Cited by 32
“Furthermore, we also explored the exhaustion status of T cells purified from vaccinated mice with HER2 peptides-pulsed different DCs. Consistent with the results shown in in vitro studies, CD8 + T cells purified from both blood and tumor tissues in vaccinated mice with HER2 peptide-loaded senescent…”
ResultImmunometabolism of ferroptosis in the tumor microenvironment
Lupica-Tondo, G. L., Arner, E. N., Mogilenko, D. A., & Voss, K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1441338 · Cited by 31
“Tumor-derived oxidized lipids can decrease antigen presentation by DCs in mice by reducing MHCI expression (120).”
BackgroundRole of dendritic cell metabolic reprogramming in tumor immune evasion
Plebanek, M. P., Sturdivant, M. S., DeVito, N. C., & Hanks, B. A. (2020) · International Immunology · doi:10.1093/intimm/dxaa036 · Cited by 31
Wu, L., Liu, X., Lei, J., Zhang, N., Zhao, H., Zhang, J., Deng, H., & Li, Y. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008081 · Cited by 31
Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer
Liu, C., Liu, W., Huang, J. X., Wu, Z., Li, W., Chen, B., Yang, Y., Lin, H., & Xu, Y. X. (2025) · Cancer Management and Research · doi:10.2147/cmar.s538281 · Cited by 30
The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
Sieow, J. L., Gun, S. Y., & Wong, S. C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00168 · Cited by 30
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
Liang, Y., Tan, Y., Chen, G., Fan, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910268 · Cited by 30
“In addition, cellular metabolism also directs the functions of DCs [26,27].”
BackgroundDendritic cells: understanding ontogeny, subsets, functions, and their clinical applications
Li, W., Yu, C., Zhang, X., Gu, Y., He, X., Xu, R., Xu, J. F., Yu, G., & Wu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00300-8 · Cited by 30
Vascular Metabolism as Driver of Atherosclerosis: Linking Endothelial Metabolism to Inflammation
Dzobo, K. E., Hanford, K., & Kroon, J. (2021) · Immunometabolism · doi:10.20900/immunometab20210020 · Cited by 29
Lu, Y., Shi, Y., Luo, Z., Guo, X., Jiang, M., Li, X., Zhang, J., Zhu, C., Yin, H., Qin, B., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101416 · Cited by 29
Mechanistic rationales for combining immunotherapy with radiotherapy
Chi, A., & Nguyen, N. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125905 · Cited by 29
“At last, cross presentation by DCs can also be impaired due to the accumulation of oxidized lipids as a result of oxidatively truncated lipids’ binding the heat shock protein (hsp) 70, which prevents the translocation of peptide-MHC complex to the cell surface (73, 74).”
BackgroundIn situ vaccination caused by diverse irradiation-driven cell death programs
Wang, Y., Li, Y., Yang, Y., Swift, M. L., Zhang, Z., Wu, S., Sun, Y., & Yang, K. (2024) · Theranostics · doi:10.7150/thno.86004 · Cited by 29
“…lipid peroxidation associated with ferroptosis can serve as a "find me" signal facilitating the recognition, phagocytosis and presentation of tumor antigens by DCs, which activates CD8 + cytotoxic T cells, promotes the release of IFN-γ , and consequently enhances anti-tumor immunity [221, 222].”
BackgroundFa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells
Almeida, L., & Everts, B. (2021) · European Journal of Immunology · doi:10.1002/eji.202048944 · Cited by 30
Lipid Droplets as Regulators of Metabolism and Immunity
Boucher, D. M., Vijithakumar, V., & Ouimet, M. I. (2021) · Immunometabolism · doi:10.20900/immunometab20210021 · Cited by 28
“Mechanistically, accumulation of lipids that have undergone oxidative modification within cytosolic LDs results in recruitment and trapping of the major stress-induced peptide chaperone heat shock protein 70 (Hsp70) [212,213].”
BackgroundMetabolic regulation of immune responses to cancer
Wißfeld, J., Werner, A., Yan, X., ten Bosch, N., & Cui, G. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0381 · Cited by 27
Mammalian lipid droplets: structural, pathological, immunological and anti-toxicological roles
Hammoudeh, N., Soukkarieh, C., Murphy, D. J., & Hanano, A. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101233 · Cited by 27
Mei, Z., Li, H., Huang, C., Ma, S., Li, Y., Deng, P., Zhou, S., Qian, A., Yang, B., & Li, J. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03478-9 · Cited by 26
Diverse effects of obesity on antitumor immunity and immunotherapy
Dyck, L., & Lynch, L. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.004 · Cited by 26
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
Evans, S. T., Jani, Y. C., Jansen, C. S., Yıldırım, A., Kalemoglu, E., & Bilen, M. A. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2342599 · Cited by 26
“68 Additionally, within the RCC TME, tumor-associated immune cells including T-cells and NK cells, often exhibit compromised mitochondrial function.”
BackgroundLipid composition dictates the rate of lipid peroxidation in artificial lipid droplets
Lange, M., Wagner, P. V., & Fedorova, M. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1898603 · Cited by 25
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
Volponi, C., Gazzillo, A., & Bonavita, E. (2022) · Cancers · doi:10.3390/cancers14246151 · Cited by 24
“In HCC, DCs have been shown to increase the uptake of extracellular lipids, particularly by accumulating oxidatively truncated lipids, which can alter their functionality by inhibiting the cross-presentation [76,77].”
BackgroundImmunometabolism of dendritic cells in health and disease
Guo, C., & Chi, H. (2023) · Advances in immunology · doi:10.1016/bs.ai.2023.10.002 · Cited by 24
Wang, G., Shen, X., Jin, W., Song, C., Dong, M., Zhou, Z., & Wang, X. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06895-0 · Cited by 23
“Furthermore, multiple studies indicate that lipid accumulation in tumor tissues can mediate the exhaustion of in fi ltrating T cells in the tumor microenvironment [84 – 86].”
Impact of mitochondrial dysfunction on the antitumor effects of immune cells
Wang, Q., Yin, X., Huang, X., Zhang, L., & Lu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1428596 · Cited by 23
Lipid metabolism in myeloid cell function and chronic inflammatory diseases
Ito, A., & Suganami, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1495853 · Cited by 23
Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response
Yao, Y., Shi, Y., Gao, Z., Sun, Y., Yao, F., & Ma, L. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00148.2022 · Cited by 23
Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer
Zarrella, S., Miranda, M. R., Covelli, V., Restivo, I., Novi, S., Pepe, G., Tesoriere, L., Rodriquez, M., Bertamino, A., Campiglia, P., et al. (2025) · Metabolites · doi:10.3390/metabo15040221 · Cited by 22
Metabolic manipulation of the tumour immune microenvironment
Wan, M., Ding, Y., Li, Z., Wang, X., & Xu, M. (2021) · Immunology · doi:10.1111/imm.13444 · Cited by 22
“They found that the LXRα ligand was expressed in both human and murine tumours and inhibited the expression and secretion of CCR7 by mature dendritic cells into the corresponding lymphatic organs, thus impairing antigen presentation by DCs [45].”
BackgroundCholesterol and Immune Microenvironment: Path Towards Tumorigenesis
El-Fattah, E. E. A., Michel, R., & Borahay, M. A. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00542-y · Cited by 21
“Decrease DC antigen presentation CT26 and MC38 colon carcinomas, EL4 lymphoma, LLC (Lewis Lung Carcinoma), and B16F10 melanoma [74] reduced capacity to process antigens CT-26 and MC38 colon carcinomas, B16F10 melanoma, EL4 lymphoma, and DA3 breast carcinoma [75]”
Lipid Metabolism in Tumor-Associated Natural Killer Cells
Chen, Y., & Sui, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_5 · Cited by 21
Metabolism of Immune Cells in the Tumor Microenvironment
Jung, J. G., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_13 · Cited by 20
A therapeutic DC vaccine with maintained immunological activity exhibits robust anti-tumor efficacy
Lu, Y., Shi, Y., Liu, Y., Luo, Z., Zhang, J., Jiang, M., Li, X., Liu, X., Guo, X., Qin, B., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.059 · Cited by 20
López-López, Á., Godzień, J., Soldevilla, B., Gradillas, A., López‐Gonzálvez, Á., Lens‐Pardo, A., Salvia, A. L., Martínez, M. C. R., García‐Carbonero, R., & Barbas, C. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461233 · Cited by 20
Palacios, D., Busto, M. D., Albillos, S. M., & Ortega, N. (2021) · LWT · doi:10.1016/j.lwt.2021.112600 · Cited by 19
Age- and diet-instructed metabolic rewiring of the tumor–immune microenvironment
Plata-Gómez, A. B., & Ho, P. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241102 · Cited by 20
A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids
Yu, Y., Gao, L., Wang, Y., Xu, B., Maswikiti, E. P., Li, H., Peng, Z., Tao, P., Xiang, L., Gu, B., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.751086 · Cited by 19
Adipose tissue dendritic cells in steady‐state
Macdougall, C. E., & Longhi, M. P. (2018) · Immunology · doi:10.1111/imm.13034 · Cited by 15
Ho, N. I., Veld, L. G. M. H. I. ‘., van der Sluijs, J. V. E., Heuts, B. M. H., Looman, M. W. G., Kers‐Rebel, E. D., van den Dries, K., Dolstra, H., Martens, J. H. A., Hobo, W. A., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007082 · Cited by 18
Kim, S. Y., Tang, M., Lu, T., Chih, S. Y., & Li, W. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149045 · Cited by 18
Immune metabolism: a bridge of dendritic cells function
Sun, Y., Zhou, L., Chen, W., Zhang, L., Zeng, H., Sun, Y., Long, J., & Yuan, D. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1897124 · Cited by 18
“For example, oxidized lipids can directly inhibit DCs antigen presentation in cancer, thereby resulting in immune evasion [9, 91].”
BackgroundThe dynamic behavior of lipid droplets in the pre-metastatic niche
Shang, C., Qiao, J., & Guo, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03207-0 · Cited by 18
Perez-Medina, M., Benito-Lopez, J. J., Aguilar‐Cázares, D., & López-González, J. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104821 · Cited by 17
“The accumulation of oxidized lipids impedes antigen cross-presentation by diminishing MHC-I molecules on the DC surface [126].”
Metadata
- Authors
- Cao, W., Ramakrishnan, R., Tuyrin, V. A., Veglia, F., Condamine, T., Amoscato, A., Mohammadyani, D., Johnson, J. J., Min Zhang, L., Klein-Seetharaman, J., Celis, E., Kagan, V. E., & Gabrilovich, D. I.
- Affiliations
- Moffitt Cancer Center (US)
- University of Pittsburgh (US)
- The Wistar Institute (US)
- Molecular Core, H. Lee Moffitt Cancer Center and Research Institute , Tampa, FL 33612
- Division of Metabolic and Vascular Health, Medical School, University of Warwick , Coventry CV4 7AL,
- Corresponding author
- Gabrilovich, Dmitry I
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 192
- Issue
- 6
- Pages
- 2920-2931
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3998104
- OpenAlex
- W2149025737
- Cited by
- 302
- References
- 53
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 27 · 2023: 24 · 2022: 40 · 2021: 48 · 2020: 29 · 2019: 21 · 2018: 13 · 2017: 21 · 2016: 7 · 2015: 5 · 2014: 3
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA165065, R01CA136828, R01CA165065, P30CA010815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- oxidized lipids, cross-presentation, dendritic cells, dendritic cell dysfunction, antitumor immunity, triglycerides, cholesterol esters, fatty acids, peptide-MHC class I complexes, tumor-derived factors, tumor immunology
- MeSH terms
- Acetylcysteine, Animals, Histocompatibility Antigens Class II, Cells, Cultured, Dendritic Cells, Flow Cytometry, Humans, Interferon-gamma, Lipids, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Ovalbumin, Oxidation-Reduction, Peptide Fragments, Histocompatibility Antigens Class I, Cysteine Proteinase Inhibitors, Culture Media, Conditioned, Antigen Presentation, Microscopy, Confocal, Cross-Priming, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.